Home » Topics » Regulatory

Regulatory
RSS

Swissmedic approves Glivec for first-line treatment of CML

Dec. 5, 2002

Axcan receives approvable letter for Photofrin

Dec. 4, 2002

Lexapro oral solution provides new option for depressed patients

Dec. 4, 2002

Taxotere approved for first-line therapy in NSCLC

Dec. 4, 2002

Nabi files BLA for use of Nabi-HB in liver transplant patients

Nov. 29, 2002

Teriparatide approved by the FDA to treat osteoporosis

Nov. 28, 2002

Lilly receives FDA approval for Strattera

Nov. 28, 2002

Embosphere Microspheres approved for treatment of uterine fibroid

Nov. 28, 2002

European Commission grants marketing authorization for Zavesca

Nov. 27, 2002

Expanded indication for EmdogainGel in E.U.

Nov. 27, 2002

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...